The pharmacy maintains dedicated clean-room suites for peptide reconstitution and lyophilization, minimizing cross-contamination risk that plagues general compounders
Our projected 24% reduction in cardiovascular events in persons with overweight or obesity but without cardiovascular disease from tirzepatide compares favorably to the well-publicized SELECT trial published last year involving another weight-loss medication Wegovy (semaglutide 2.4 milligram), which was studied in persons with cardiovascular disease and showed a 20% reduction in future cardiovascular events, said Wong, who also previously published a similar analysis of semaglutide estimating an 18% risk reduction in persons without cardiovascular disease
exposure duration, sampling schedule, and concentration verification
While compounded alternatives gained traction when there were supply constraints, the FDAs intervention highlights the regulatory and evidentiary advantages of approved therapies including FDA-reviewed labeling, established safety and efficacy data, and regulated manufacturing oversight
Neither outcome reflects a failure of the medication or of the individual
. in a cohort of healthy-weight men